| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4198e8cfa9f75ca6133d3252f1e5f9a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a845d801424231dc1940bd5fbeeba85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c66898b60a1612dabb3dfd137ce4010a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4813537acc08fd285e66c74c7a3a16aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0bc0c8d9cf6981d3cbdeb558da64caf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 |
| filingDate |
2005-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7de53b15c8e05e2e6b0bb28f41f67946
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3303561db4665be7e32c1fc9eafe50d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1e606fd5b37eca3fcc18ba2c8f6b3db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_834c8939d2dfa330a2032b3ed263e02a |
| publicationDate |
2005-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005110457-A2 |
| titleOfInvention |
Treatment of eating disorders and induction of lipolysis |
| abstract |
The present invention relates to PYY or functional equivalents thereof for use in pharmaceutical compositions. The pharmaceutical compositions are in particular useful in the treatment of eating disorders, such as disorders characterised by cravings and binges. The invention further discloses the use of said composition for regulation of lipolysis, e.g. stimulation of lipolysis for the treatment of obesity. The invention further relates to methods of treatment using said compositions. Further included is the combination of PYY or functional equivalents thereof with a secondary active ingredient such as an anti-emetic drug. |
| priorityDate |
2004-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |